← Open Payments lookup

KRISTIN LUTZ: Open Payments

NPI 1639826852 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$489 in 22 payments from 11 companies in 2025. Trend: 2023 $721 · 2024 $396 · 2025 $489

Food & beverage: $489
CompanyPaymentsAmount
Novo Nordisk Inc5$123
ABBVIE INC.4$89
Sumitomo Pharma America, Inc.3$71
Exact Sciences Corporation2$45
Astellas Pharma US Inc2$43
Merck Sharp & Dohme LLC1$31
Lilly USA, LLC1$21
Bayer Healthcare Pharmaceuticals Inc.1$21
Xeris Pharmaceuticals, Inc.1$16
Seqirus USA Inc1$16

Products named: Wegovy, GEMTESA, The Cologuard Plus Collection Kit, Veozah, VRAYLAR, UBRELVY, CAPVAXIVE, Ozempic.

Industry payments across MD — which companies pay providers there.